Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones12-10

DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slumped 0.13% to $15.24 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.62% to 19,736.69 and Dow Jones Industrial Average falling 0.54% to 44,401.93.

This was the stock's fifth consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed $46.66 short of its 52-week high ($61.90), which the company achieved on July 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.41% to $4.82, Fortress Biotech Inc. (FBIO) rose 9.76% to $2.25, and Viking Therapeutics Inc. $(VKTX)$ fell 0.89% to $50.35.

Trading volume (301,114) remained 75,233 below its 50-day average volume of 376,347.

Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 09, 2024 17:24 ET (22:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490336081?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-10 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490336081","market":"sg","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slumped 0.13% to $15.24 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.62% to 19,736.69 and Dow Jones Industrial Average  falling 0.54% to 44,401.93. \n</p>\n<p>\n     This was the stock's fifth consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed $46.66 short of its 52-week high ($61.90), which the company achieved on July 31st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 0.41% to $4.82, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) rose 9.76% to $2.25, and Viking <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. <a href=\"https://laohu8.com/S/VKTX\">$(VKTX)$</a> fell 0.89% to $50.35. \n</p>\n<p>\n     Trading volume (301,114) remained 75,233 below its 50-day average volume of 376,347. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 09, 2024 17:24 ET (22:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-10 06:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2490336081","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490336081","pubTimestamp":1733783040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slumped 0.13% to $15.24 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.62% to 19,736.69 and Dow Jones Industrial Average  falling 0.54% to 44,401.93.This was the stock's fifth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed $46.66 short of its 52-week high , which the company achieved on July 31st.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  fell 0.41% to $4.82, Fortress Biotech Inc.  rose 9.76% to $2.25, and Viking Therapeutics Inc.  fell 0.89% to $50.35.Trading volume  remained 75,233 below its 50-day average volume of 376,347.Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024.This content was created by MarketWatch, which is operated by ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"尽管当天下跌，Corbus Pharmaceuticals Holdings Inc.股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1},"content_text":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slumped 0.13% to $15.24 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.62% to 19,736.69 and Dow Jones Industrial Average  falling 0.54% to 44,401.93. \n\n\n     This was the stock's fifth consecutive day of losses. \n\n\n     Corbus Pharmaceuticals Holdings Inc. closed $46.66 short of its 52-week high ($61.90), which the company achieved on July 31st. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.41% to $4.82, Fortress Biotech Inc. (FBIO) rose 9.76% to $2.25, and Viking Therapeutics Inc. $(VKTX)$ fell 0.89% to $50.35. \n\n\n     Trading volume (301,114) remained 75,233 below its 50-day average volume of 376,347. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2024 17:24 ET (22:24 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490336081"}